Filter articles using the following links

World Orphan Drug Congress Europe 2020 – Live Digital

4th Annual Gene Therapy for Rare Disorders Europe – Virtual

EURETINA 2020 – Virtual

Ophthalmology Futures Retina – Virtual Forum

GenSight Biologics Announces Publication of Meta-Analysis Confirming that Spontaneous Recovery in LHON is rare in the Journal of Neuro-Ophthalmology

GenSight Biologics reports new analysis demonstrating statistically significant and clinically meaningful difference between visual outcomes in LUMEVOQ®-treated patients and natural history of Leber Hereditary Optic Neuropathy (LHON)

UMDF Power Surge 2020 – online event

2020 Annual Scientific Meeting ASRS – Virtual format

GenSight Biologics reports final REALITY natural history study results confirming poor spontaneous recovery for LHON patients with ND4 mutation

GenSight Biologics reports sustained efficacy and safety among LHON patients three years after LUMEVOQ® treatment